Your browser doesn't support javascript.
loading
Prognostic value of geriatric nutritional risk index in patients with diffuse large B-cell lymphoma: a meta-analysis
Yan, Chengkun; Xie, Yanyou; Hua, Yaqi; Wu, Jiehua; Fu, Huanxu; Cheng, Zhiqiang; Li, Sihui.
Afiliación
  • Yan, Chengkun; Nanchang University. The Second Affiliated Hospital. Jiangxi. China
  • Xie, Yanyou; Nanchang University. The Second Affiliated Hospital. Jiangxi. China
  • Hua, Yaqi; Nanchang University. The Second Affiliated Hospital. Jiangxi. China
  • Wu, Jiehua; Nanchang University. The Second Affiliated Hospital. Jiangxi. China
  • Fu, Huanxu; Nanchang University. School of Nursing. Jiangxi. China
  • Cheng, Zhiqiang; Nanchang University. School of Nursing. Jiangxi. China
  • Li, Sihui; Nanchang University. The First Affiliated Hospital. Jiangxi. China
Clin. transl. oncol. (Print) ; Clin. transl. oncol. (Print);26(2): 515-523, feb. 2024.
Article en En | IBECS | ID: ibc-230195
Biblioteca responsable: ES1.1
Ubicación: ES15.1 - BNCS
ABSTRACT
Background Geriatric nutritional risk index (GNRI) on the prognosis of patients with diffuse large B-cell lymphoma (DLBCL) remains unclear. The purpose of this meta-analysis was to discuss the value of the GNRI in evaluating long-term outcomes in DLBCL. Methods We systematically and roundly retrieved PubMed, Cochrane Library, Embase, Scopus and Web of Science electronic databases from inception of the databases to March 20, 2023. At the same time, we calculated the pool hazard ratios (HRs) with their 95% confidence interval (CI) for overall survival and progression-free survival to assess the effect of GNRI on the prognosis of DLBCL patients. Results In our primary meta-analysis, 7 trials with a total of 2448 patients were enrolled. Results showed that lower level of GNRI was related to poorer overall survival (HR = 1.78, 95% CI 1.27, 2.50, p < 0.01) and worse progression-free survival (HR = 2.31, 95% CI 1.71, 3.13, p < 0.01) in DLBCL patients. Conclusion The results of our meta-analysis indicate that a lower GNRI significantly associated with poorer prognosis for DLBCL. It is believed that GNRI was a promisingly predictive indicator of survival outcomes in DLBCL patients. However, large multicenter prospective studies are necessary to verify the results (AU)
Asunto(s)
Palabras clave
Buscar en Google
Colección: 06-national / ES Base de datos: IBECS Asunto principal: Linfoma de Células B Grandes Difuso Límite: Humans Idioma: En Revista: Clin. transl. oncol. (Print) Año: 2024 Tipo del documento: Article
Buscar en Google
Colección: 06-national / ES Base de datos: IBECS Asunto principal: Linfoma de Células B Grandes Difuso Límite: Humans Idioma: En Revista: Clin. transl. oncol. (Print) Año: 2024 Tipo del documento: Article